NCT06034743: A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
- State
- Completed
- Phase
- Phase 3
- People
- 796 taking part
- Started
- 22 Nov 2023
- Primary completion
- 21 May 2025
- Arms
- 2 mg baxdrostat, 1 mg baxdrostat
- Results
- Posted on the registry
- Papers
- doi:10.1038/s41440-025-02297-7, doi:10.1056/nejmoa2507109, doi:10.1093/ajh/hpae051
- 13 Sep 2023: Trial registered
- 22 Nov 2023: Trial started
- 10 Oct 2025: Trial completed
- 30 Jul 2026: Trial results posted